Feature|Videos|July 21, 2025
Video Interview With Chris Hagen, President of SCIEX
Author(s)SCIEX, Chris Hagen
Chris Hagen, President of SCIEX, shares his vision for the company and introduces the new ZenoTOF 8600 system, featuring electron activated dissociation (EAD) that provides more complete molecule identification and characterization and ZTScan for enhanced Q1 window selectivity.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Genentech Expands RNAi Pipeline Through Global Licensing Deal
2
FAQ: What You Need to Know About Agentic AI in Drug Discovery
3
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
4
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
5